跳至主要内容
临床试验/ACTRN12618000130268
ACTRN12618000130268进行中(未招募)3 期

A randomised placebo controlled trial of the effect of BLIS probiotic, S. salivarius (K12) on Otitis media (ear infections) and Upper Respiratory Tract Infections amongst 6-24 month old children, as measured by medical record events.

Julian Crane0 个研究点目标入组 420 人开始时间: 2018年1月30日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
420

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
6 Months 至 6 Months(—)
性别
All

入选标准

  • Infant must be enrolled in a medical practice, planning to live in the Hutt Valley, Wellington or Christchurch regions for the duration of the study,

排除标准

  • Infants with serious medical conditions such as congenital heart conditions, severe immunodeficiency, families who plan to permanently move from the Wellington/Christchurch regions during the 18 month study period. Infants already receiving regular BLIS probiotics or a parent planning to give them to their child, children with a severe dairy allergy.

研究者

发起方
Julian Crane

相似试验